Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma

American Journal of Surgery

Volumn 206, Issue 4, 2013, Pages 586-593

  Karatzas, Theodore ^a   Vasileiadis, Ioannis ^b   Kapetanakis, Stylianos ^c   Karakostas, Efthimios ^b   Chrousos, George ^d   Kouraklis, Gregory ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Venizeleio Pananeio Hospital   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Papillary thyroid carcinoma; Papillary thyroid microcarcinoma; Prognosis; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY THYROID MICROCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; THYROID CARCINOMA; THYROIDECTOMY;

PAPILLARY THYROID CARCINOMA; PAPILLARY THYROID MICROCARCINOMA; PROGNOSIS; RISK FACTORS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENTAL FINDINGS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT;

EID: 84885085163     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2013.02.008     Document Type: Article

References (38)

1. R. Siegel, E. Ward, and O. Brawley Cancer statistics 2011:the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. R. Lloyd, R. De Lellis, and P. Heitz World Health Organization classification of tumours: pathology and genetics of tumours of the endocrine organs 2000 IARC Press International Agency for Research on Cancer Lyon, France
3. L. Leenhardt, P. Grosclaude, L. Cherie-Challine, and Thyroid Cancer Committee Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee Thyroid 14 2004 1056 1060
4. S.M. Chow, S.C. Law, and J.K. Chan Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality Cancer 98 2003 31 40
5. I.D. Hay, M.E. Hutchinson, and T. Gonzalez-Losada Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period Surgery 144 2008 980 988
6. P. Kjellman, J. Zedenius, and G. Lundell Predictors of outcome in patients with papillary thyroid carcinoma Eur J Surg Oncol 32 2006 345 352
7. J.D. Lin, M.J. Huang, and T.C. Chao Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases Thyroid 9 1999 1227 1235
8. E.L. Mazzaferri, and S.M. Jhiang Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 1994 418 428
9. M.J. Schlumberger Papillary and follicular thyroid cancer N Engl J Med 5 1998 297 306
10. E.L. Mazzaferri Papillary thyroid carcinoma: factors influencing prognosis and current therapy Semin Oncol 14 1987 315 332
11. E. Roti, E.C. degli Uberti, and M. Bondanelli Thyroid papillary microcarcinoma: a descriptive and meta-analysis study Eur J Endocrinol 159 2008 659 673
12. S. Grodski, T. Brown, and S. Sidhu Increased incidence of thyroid cancer is due to increased pathologic detection Surgery 144 2008 1038 1043
13. L. Wartofsky Management of papillary microcarcinoma: primum non nocere? J Clin Endocrinol Metab 96 2012 1169 1172
14. D.S. Cooper, G.M. Doherty, and B.R. Haugen Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
15. D.T. Haymart, M. Cayo, and H. Chen Papillary thyroid microcarcinomas: big decision for a small tumor Ann Surg Oncol 16 2009 3132 3139
16. B.H. Lang, C.Y. Lo, and W.F. Chan Staging systems for papillary thyroid carcinoma: a review and comparison Ann Surg 245 2007 366 378
17. Y. Ito, A. Miyauchi, and T. Jikuzono Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC-AJCC TNM classification and stage grouping World J Surg 31 2007 838 848
18. I. Sugitani, N. Kasai, and Y. Fujimoto A novel classification system for patients with PTC: addition of the new variable of large (3 cm or greater) nodal metastases and reclassification during the follow-up period Surgery 135 2004 139 148
19. D.T. Hughes, M.R. Haymart, and B.S. Miller The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years Thyroid 21 2011 231 236
20. B.S. Koo, E.C. Choi, and Y.H. Yoon Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma Ann Surg 249 2009 840 844
21. G. Mercante, C. Frasoldati, and C. Pedroni Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary thyroid microcarcinoma of the thyroid: results of a study in 445 patients Thyroid 19 2009 707 716
22. D. Zimmerman, I.D. Hay, and I.R. Gough Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades Surgery 104 1988 1157 1166
23. M. Bansal, G. Mantha, and Y.E. Nikiforov Molecular and histopathological features of multifocal papillary thyroid carcinomas Mod Pathol 23 2010 126A 133A
24. E. Baudin, J.P. Travagli, and J. Ropers Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience Cancer 83 1998 553 559
25. H. Mazeh, Y. Samet, and D. Hochstein Multifocality in well-differentiated thyroid carcinomas calls for total thyroidectomy Am J Surg 201 2001 770 775
26. N. Arora, H.K. Turbendian, and M.A. Kato Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 19 2009 473 477
27. E. Mirallie, J. Visset, and C. Sagan Localization of cervical node metastasis of papillary thyroid carcinoma World J Surg 23 1999 970 973
28. E.L. Mazzaferri, and R.T. Kloos Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer J Clin Endocrinol Metab 86 2001 1447 1463
29. I. Vasileiadis, E. Karakostas, and G. Charitoudis Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients Eur J Clin Invest 42 2012 657 664
30. A. Pisanu, O. Reccia, and O. Nardello Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors World J Surg 33 2009 460 468
31. S.I. Sherman Thyroid carcinoma Lancet 361 2003 501 511
32. K.Y. Bilimoria, D.J. Bentrem, and C.Y. Ko Extent of surgery affects survival for papillary thyroid cancer Ann Surg 246 2007 375 381
33. Y. Ito, C. Tomoda, and T. Uruno Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28 2004 1115 1121
34. I.R. McDougall, and C.A. Camargo Treatment of micropapillary carcinoma of thyroid: where do we draw the line? Thyroid 32 2007 279 281
35. E. Dunki-Jacobs, K. Grannan, and S. McDonough Clinically unsuspected papillary microcarcinomas of the thyroid; a common finding with favorable biology? Am J Surg 203 2012 140 144
36. C. Cappelli, M. Castellano, and M. Braga Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a monoinstitutional experience J Surg Oncol 95 2007 555 560
37. K.L. Lin, O.C. Wang, and X.H. Zhang The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma Ann Surg Oncol 17 2010 3294 3300
38. Y.J. Park, Y.A. Kim, and Y.J. Lee Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF (V600E) mutation, clinicopathological features, and immunohistochemical findings Head Neck 32 2010 38 45